Short interest for TC BioPharm (Holdings) gives investors a sense of the degree to which investors are betting on the decline of TC BioPharm (Holdings)'s stock. Short interest data is updated every two weeks.

TC BioPharm (Holdings) Stock (NASDAQ:TCBP), Short Interest Report

TC BioPharm (Holdings)

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALLR

EGOX

FAAS

FLGC

GNLN

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

HUBC

LGVC

MDIA

NUTX

RELI

SPCB

STIX

TCBP

XXII

ZCMD

NIVF

Shares of  Reliance Global Group, Inc.  (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial results for the year ended Dec 31, 2023.

Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket

Earnings

Eurozone

Commodities

Global

Intraday Update

ACHL

ALUR

CADL

EFTR

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday.

The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&amp;P 500 also fell, dropping, 0.28% to 5,197.03.

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results

ABIO

ADXN

AQST

AXTI

CASA

DXYZ

EIGR

ENPH

GCTS

GRRR

HUBS

Kintara Therapeutics, Inc. - Common Stock

KTRA

KYCH

LEVI

MGNX

MSTR

Nuveen California Dividend Advantage Municipal Fund 2

ONMD

PARA

RENT

SLNA

SMXT

SPWH

STAA

TVGN

VIEW

VSTE

XTIA

ZETA

Shares of  STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance.

STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings) PLC

Benchmark analyst Bill Sutherland reiterates Huron Consulting Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURN#NASDAQ">HURN</a>) with a Buy and maintains $140 price target.

Price Target

Reiteration

Analyst Ratings

HURN

Benchmark Reiterates Buy on Huron Consulting Gr, Maintains $140 Price Target

JP Morgan analyst Tami Zakaria maintains PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) with a Overweight and lowers the price target from $140 to $130.

PCAR

JP Morgan Maintains Overweight on PACCAR, Lowers Price Target to $130

Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) plans to construct a data center in Vietnam to meet legal requirements for local data storage and to cater to increasing demand in one of Asia&#8217;s fastest-growing economies. 
Currently, Alibaba rents server space from Vietnamese state-owned telecommunications companies Viettel and VNPT. 
The arrangement follows Vietnam&#8217;s contentious 2022 law mandating that companies store data within the country—a regulation that sparked resistance from major tech firms like&nbsp;Alphabet Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)&nbsp;Google&nbsp;and&nbsp;Amazon.Com Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), the Nikkei Asia&nbsp;<a target="_blank" href="https://asia.nikkei.com/Business/Technology/Alibaba-to-build-Vietnam-data-center-to-follow-local-storage-law" rel="noreferrer noopener">reports</a>.
Dang Minh Tam, Alibaba Cloud&#8217;s solution architect lead, noted that the company uses colocation services from these state companies to store client data locally. It also maintains backups across its server farms in regions including Taiwan and Singapore.&nbsp;
The move is part of Alibaba&#8217;s strategy to ensure better security and control over its data and potentially reduce costs and liability issues associated with multi-company data management.&nbsp;
Companies including&nbsp;Nvidia Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>),&nbsp;Apple Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and&nbsp;Lam Research Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) have reached out to Vietnam to diversify their supply chain base amid heightening geopolitical tensions between the US and China.
Lam Research&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/03/37886908/lam-research-eyes-vietnam-to-diversify-supply-chain-away-from-china-report" rel="noreferrer noopener">weighed the supply chain shift</a>&nbsp;to Vietnam, with the Vietnamese government canvassing the former to commit $1 billion to local production efforts.
&nbsp;Apple&nbsp;<a target="_blank" href="https://www.benzinga.com/government/24/04/38460042/apple-strengthens-supply-chain-in-china-while-growing-presence-in-southeast-asia-and-india" rel="noreferrer noopener">suppliers in Vietnam</a>&nbsp;increased by 40% to 35 in 2023.
Meanwhile, Nvidia tapped&nbsp;<a target="_blank" href="https://www.benzinga.com/government/23/12/36171360/whats-going-on-with-nvidia-stock-monday" rel="noreferrer noopener">Vietnamese tech firms</a>&nbsp;for AI development.
Alibaba stock lost over 11% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Invesco Golden Dragon China ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGJ#NASDAQ">PGJ</a>) and&nbsp;Tidal Trust II CoreValues Alpha Greater China Growth ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGRO#NYSE">CGRO</a>).
Price Action: BABA shares are trading higher by 1.28% at $75.78 at the last check on Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors
Alibaba Photo by zhu difeng on Shutterstock

Government

Regulations

Tech

Media

AAPL

AMZN

BABA

CGRO

GOOG

GOOGL

LRCX

NVDA

PowerShares Golden Dragon Halter USX China Portfolio

After Nvidia and Apple, Alibaba Chases Vietnam: New Data Center to Boost Control and Meet Local Laws

JP Morgan analyst Steven Alexopoulos maintains MVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVBF#NASDAQ">MVBF</a>) with a Overweight and lowers the price target from $28 to $25.

MVBF

JP Morgan Maintains Overweight on MVB Financial, Lowers Price Target to $25

Management

TSLA

Tesla's Top HR Executive Allie Arebalo Has Left The Company

Benchmark analyst Bruce Jackson reiterates NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) with a Buy and maintains $18 price target.

Benchmark Reiterates Buy on NeoGenomics, Maintains $18 Price Target

JP Morgan analyst Andrea Teixeira maintains Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) with a Neutral and lowers the price target from $66 to $60.

JP Morgan Maintains Neutral on Molson Coors Beverage, Lowers Price Target to $60

Pseudonymous crypto trader Altcoin Sherpa took to his social media account to share valuable insights on how to interpret <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38528542/bitcoin-dogecoin-shiba-inu-pumped-after-the-last-fomc-meeting-will-history-repeat-on-wedne">weakening support levels</a> in the Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) market.
What Happened: Sherpa uses an analogy of a dropped ball to explain how the first bounce off a support level is typically the strongest, with subsequent bounces becoming progressively weaker. 
He states that the first drop has the best bounce and then there are weaker bounces. He goes on to add that a classic example is Bitcoin at the &#8220;unbreakable&#8221; $6,000 level in 2018.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Today&#39;s <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> post will be on support WEAKENING every time it is touched. I like to use the analogy of a dropped ball. The first time you drop it, it has the best bounce off the ground. Then weaker and weaker bounces after. The classic example of this is <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> at the… <a href="https://t.co/4HVs6uSx3N">pic.twitter.com/4HVs6uSx3N</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1785305011129319878?ref_src=twsrc%5Etfw">April 30, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also credits fellow trader CryptoCred for the concept of "first test, best test," which highlights the importance of the initial reaction to a support level. The trader suggests that the strongest bounce is often due to a combination of resting orders and late shorters getting caught off guard.
However, as the price revisits the same support level multiple times, the reactions tend to weaken. But zooming out <a href="https://twitter.com/AltcoinSherpa/status/1785305047074525508">reveals</a> that the market is still very bullish. Even a 50% retracement to $40,000 would not necessarily invalidate the overall bullish sentiment, according to Altcoin Sherpa.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is the first real pause we&#39;ve had on the 1W in a long time. Zooming out, we are still very bullish and there are a lot of levels to break before this turns bearish. We could go all the way down to 40k and still be fine IMO. 50% retrace after all that is ok. <a href="https://t.co/wiD6OvA1Y7">pic.twitter.com/wiD6OvA1Y7</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1785305047074525508?ref_src=twsrc%5Etfw">April 30, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He writes, "Those previous buyers are getting their orders filled, and there is less and less support the more times it&#8217;s tapped."  This phenomenon can lead to consolidation at the support level before a potential breakdown.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38500667/raoul-pal-predicts-crypto-to-enter-banana-zone-soon-and-100-trillion-market-cap-within-10-">Raoul Pal Predicts Crypto To Enter &#8216;Banana Zone&#8217; Soon And $100 Trillion Market Cap Within 10 Years</a>
Why It Matters: While this pattern is most observed during liquidation events characterized by long wicks and high volatility, Altcoin Sherpa emphasizes that context matters.
The bouncing ball analogy is more applicable to ranging markets and bearish market structures. In bullish market structures, prices may revisit lows before strongly taking off again, as seen in Bitcoin&#8217;s 2021 rally to $60,000.
The Bitcoin market is currently in a ranging structure with no clear trend on lower time frames. Looking ahead, Altcoin Sherpa believes that bullish catalysts, such as the upcoming election and improving macroeconomic conditions, support remaining long on Bitcoin.
While traders are advised to be prepared for short-term volatility and potentially lower prices, Sherpa suggests avoiding panic selling and maintaining a long-term perspective.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp; <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38499287/ethereums-bottom-against-bitcoin-still-likely-a-few-months-away-predicts-crypto-analyst">Ethereum&#8217;s Bottom Against Bitcoin &#8216;Still Likely A Few Months Away,&#8217; Predicts Crypto Analyst</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

This Trader Sees Bitcoin Dropping To $40,000 And Still Be Fine: 'Expect Lower Prices But Don't Panic Sell'

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) with a Buy and maintains $50 price target.

SGRY

Benchmark Reiterates Buy on Surgery Partners, Maintains $50 Price Target

Financial giants have made a conspicuous bearish move on MongoDB. Our analysis of options history for MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) revealed 16 unusual trades.
Delving into the details, we found 31% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $508,740, and 4 were calls, valued at $152,105.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $320.0 to $430.0 for MongoDB over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for MongoDB options trades today is 277.09 with a total volume of 397.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for MongoDB's big money trades within a strike price range of $320.0 to $430.0 over the last 30 days.
<h3>MongoDB Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714576609_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$39.35</td>
<td>$39.2</td>
<td>$39.2</td>
<td>$350.00</td>
<td>$78.6K</td>
<td style="text-align: right;">289</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/10/24</td>
<td>$11.45</td>
<td>$10.3</td>
<td>$11.45</td>
<td>$370.00</td>
<td>$58.4K</td>
<td style="text-align: right;">817</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$34.3</td>
<td>$32.95</td>
<td>$32.95</td>
<td>$430.00</td>
<td>$56.0K</td>
<td style="text-align: right;">20</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/03/24</td>
<td>$2.0</td>
<td>$1.85</td>
<td>$2.0</td>
<td>$355.00</td>
<td>$47.6K</td>
<td style="text-align: right;">379</td>
<td style="text-align: right;">14</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$20.25</td>
<td>$20.0</td>
<td>$20.0</td>
<td>$340.00</td>
<td>$44.0K</td>
<td style="text-align: right;">709</td>
<td style="text-align: right;">24</td>
</tr>
</tbody>
</table>

<h3>About MongoDB</h3>
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
In light of the recent options history for MongoDB, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of MongoDB</h3>
<ul>
<li>Currently trading with a volume of 326,076, the MDB's price is up by 1.77%, now at $371.64. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 29 days.</li>
</ul>
<h3>What The Experts Say On MongoDB</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $446.25.
<ul>
<li>Maintaining their stance, an analyst from Keybanc continues to hold a Overweight rating for MongoDB, targeting a price of $440. </li>
<li>In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $465. </li>
<li>Reflecting concerns, an analyst from Loop Capital lowers its rating to Buy with a new price target of $415.</li>
<li>In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $465. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for MongoDB, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Decoding MongoDB's Options Activity: What's the Big Picture?

Deep-pocketed investors have adopted a bearish approach towards Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PANW usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 40 extraordinary options activities for Palo Alto Networks. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 42% leaning bullish and 55% bearish. Among these notable options, 11 are puts, totaling $1,610,011, and 29 are calls, amounting to $2,759,376.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $200.0 to $410.0 for Palo Alto Networks over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Palo Alto Networks's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Palo Alto Networks's significant trades, within a strike price range of $200.0 to $410.0, over the past month.
<h3>Palo Alto Networks Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714576603_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$26.85</td>
<td>$26.0</td>
<td>$26.25</td>
<td>$250.00</td>
<td>$866.2K</td>
<td>1.0K</td>
<td style="text-align: right;">330</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$18.7</td>
<td>$18.45</td>
<td>$18.7</td>
<td>$300.00</td>
<td>$591.1K</td>
<td>905</td>
<td style="text-align: right;">320</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$19.85</td>
<td>$19.2</td>
<td>$19.8</td>
<td>$410.00</td>
<td>$435.6K</td>
<td>133</td>
<td style="text-align: right;">220</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$27.4</td>
<td>$27.1</td>
<td>$27.1</td>
<td>$300.00</td>
<td>$235.7K</td>
<td>841</td>
<td style="text-align: right;">135</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$48.95</td>
<td>$44.4</td>
<td>$44.42</td>
<td>$360.00</td>
<td>$223.1K</td>
<td>214</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About Palo Alto Networks</h3>
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 85,000 customers across the world, including more than three fourths of the Global 2000.
Having examined the options trading patterns of Palo Alto Networks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Palo Alto Networks's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,003,376, with PANW's price down by -1.7%, positioned at $285.95.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 20 days.</li>
</ul>
<h3>Expert Opinions on Palo Alto Networks</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $345.0.
<ul>
<li>An analyst from Oppenheimer has decided to maintain their Outperform rating on Palo Alto Networks, which currently sits at a price target of $330. </li>
<li>An analyst from Keybanc has decided to maintain their Overweight rating on Palo Alto Networks, which currently sits at a price target of $355. </li>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $350. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Palo Alto Networks options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

PANW

Behind the Scenes of Palo Alto Networks's Latest Options Trends

Financial giants have made a conspicuous bearish move on UnitedHealth Group. Our analysis of options history for UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) revealed 8 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $99,225, and 6 were calls, valued at $927,065.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $230.0 to $530.0 for UnitedHealth Group over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for UnitedHealth Group's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across UnitedHealth Group's significant trades, within a strike price range of $230.0 to $530.0, over the past month.
<h3>UnitedHealth Group 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714576598_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$83.35</td>
<td>$81.25</td>
<td>$82.1</td>
<td>$410.00</td>
<td>$246.3K</td>
<td>413</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$83.05</td>
<td>$81.1</td>
<td>$81.9</td>
<td>$410.00</td>
<td>$245.7K</td>
<td>413</td>
<td style="text-align: right;">60</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$81.6</td>
<td>$79.9</td>
<td>$80.5</td>
<td>$410.00</td>
<td>$241.5K</td>
<td>413</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/21/24</td>
<td>$255.7</td>
<td>$251.45</td>
<td>$253.89</td>
<td>$230.00</td>
<td>$126.9K</td>
<td>13</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$15.8</td>
<td>$15.65</td>
<td>$15.75</td>
<td>$490.00</td>
<td>$53.5K</td>
<td>1.1K</td>
<td style="text-align: right;">37</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 53 million members globally, including 5 million outside the U.S. as of mid-2023. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Having examined the options trading patterns of UnitedHealth Group, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of UnitedHealth Group</h3>
<ul>
<li>With a volume of 511,160, the price of UNH is up 0.08% at $484.1. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 72 days.</li>
</ul>
<h3>What Analysts Are Saying About UnitedHealth Group</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $551.4.
<ul>
<li>Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for UnitedHealth Group, targeting a price of $571. </li>
<li>An analyst from TD Cowen has decided to maintain their Buy rating on UnitedHealth Group, which currently sits at a price target of $546. </li>
<li>An analyst from Barclays persists with their Overweight rating on UnitedHealth Group, maintaining a target price of $560. </li>
<li>Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for UnitedHealth Group, targeting a price of $525. </li>
<li>Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for UnitedHealth Group, targeting a price of $555. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for UnitedHealth Group with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

A Closer Look at UnitedHealth Group's Options Market Dynamics

JP Morgan analyst John Ivankoe maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Overweight and lowers the price target from $300 to $290.

JP Morgan Maintains Overweight on McDonald's, Lowers Price Target to $290

Mastercard Inc.&nbsp;(NYSE:&nbsp;MA)&nbsp;reported fiscal first-quarter net revenues of $6.35 billion, up 10% year over year and 11% year over year on a neutral currency basis,&nbsp;beating the consensus of&nbsp;<a target="_blank" href="https://investor.mastercard.com/overview/default.aspx" rel="noreferrer noopener">$6.34 billion</a>. Adjusted EPS rose 18% year over year to $3.31, exceeding the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $3.24</a>.
Payment network net revenue rose 7% Y/Y (+8% Y/Y on a currency-neutral basis), led by growth in gross dollar volume (+10% Y/Y), cross-border volume (+18% Y/Y) and switched transactions (+13% Y/Y).&nbsp;
Also&nbsp;Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38337407/mastercards-latest-virtual-card-app-move-to-boost-contactless-payments-analyst-eyes-substantial-grow" rel="noreferrer noopener">Mastercard's&nbsp;Latest Virtual Card App Move to Boost Contactless Payments; Analyst Eyes Substantial Growth Citing Advanced Security and Digital Innovations</a>
Value-added services and solutions net revenue rose 16% and 15% on a currency-neutral basis, driven by continued strong growth in cyber and intelligence solutions and high demand for consulting, marketing, and loyalty solutions.
Total operating expenses increased 5%. Excluding the impact of special items, adjusted operating expenses increased by 9% on a currency-neutral basis, primarily due to higher personnel costs.&nbsp;
The adjusted operating margin expanded 60bps Y/Y to 58.8%.
As of March&nbsp;31, 2024, the&nbsp;company's&nbsp;customers had issued 3.4 billion Mastercard and Maestro branded cards.
During the first quarter of 2024, Mastercard repurchased 4.4&nbsp;million shares for $2.0&nbsp;billion and paid $616 million in dividends.&nbsp;
As of March 31, 2024, cash and cash equivalents stood at $9.5 billion.
"Our momentum continued this quarter, as we delivered strong revenue and earnings growth powered by healthy consumer spending, strong cross-border volume growth of 18% year-over-year, and new deal wins in every region,"&nbsp;said Michael Miebach, CEO of Mastercard.&nbsp;"We are driving growth in electronic payments by scaling innovative technologies like tokenization."
Outlook: For the second quarter, Mastercard expects net revenue growth in the&nbsp;high-end of high-single-digits&nbsp;versus the&nbsp;$6.98 billion analyst consensus estimate.&nbsp;
For fiscal 2024, Mastercard projects net revenue growth in the low-end of&nbsp;low-double-digits&nbsp;(prior expectations of high-end of low-double-digits) versus&nbsp;$28.11&nbsp;billion&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">analyst consensus estimate</a>.
Mastercard stock gained 19% in the last 12 months. Investors can gain exposure to the stock via&nbsp;SPDR Select Sector Fund – Financial&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)&nbsp;and&nbsp;IShares U.S. Financial Services ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYG#NYSE">IYG</a>).
Price Action: MA shares are down 1.35% at $445.11 at the last check Wednesday.
Also Read: <a href="https://www.benzinga.com/news/24/04/38181568/mastercard-revamps-structure-for-growth-new-teams-to-drive-core-payments-and-services" target="_blank" rel="noreferrer noopener">Mastercard Revamps Structure for Growth, New Teams to Drive Core Payments and Services</a>
Photo via Wikimedia Commons

Guidance

Mastercard Says Consumer Spending Is Healthy, Clocks 10% Revenue Growth In Q1

JP Morgan analyst Richard Choe maintains DigitalBridge Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBRG#NYSE">DBRG</a>) with a Overweight and lowers the price target from $25 to $23.

DBRG

JP Morgan Maintains Overweight on DigitalBridge Gr, Lowers Price Target to $23

Personal finance expert Suze Orman advised the host of CNN's "Who's Talking to Chris Wallace" show that leasing a car is a waste of money, so buying one is better. Here's why.&nbsp;
During her November appearance on the show, Wallace asked <a href="https://www.benzinga.com/personal-finance/24/04/38112723/suze-orman-doesnt-believe-people-are-doing-ok-despite-being-told-the-economy-is-strong-in-my-opi">Orman</a> whether it was better to lease or buy a car and told her that he leases a car. Orman did not hold back, telling Wallace why she believed leasing a car was not a good use of his money. Instead, she believes that buying the car is the better option.&nbsp;
Don't Miss:
<ul>
<li>82% of Americans aren&#8217;t using<a href="https://www.benzinga.com/money/public-hys"> this government secured 5% passive income stream</a>, are you one of them?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
</ul>
"Leasing a car is the biggest waste of money out there," she said. "If you keep it the entire time, [for] the life of it, if you take good care of it, [you will save money]. My car is going to be good for another five years. I just think it's better to buy."
This isn't something new from the finance guru, who has reiterated her stance on buying over leasing vehicles over the years. In 2018, Orman appeared on CNBC's financial show "Make It" and explained that with leasing cars, you're pouring money each month into a car that you don't own and when that lease ends, you'll have nothing to show from it.&nbsp;
"If you rent a car, you're going to rent a car year in and year out," she said.&nbsp;
Wallace said leasing makes more sense for people who don't want to deal with older cars and the repairs that come with them. You also can lease a luxury car you may not be able to afford to buy. Leasing also is an attractive option for drivers who want the advanced automotive features new cars offer.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: If the United States had access to<a href="https://www.benzinga.com/money/public-hys-avgamerican"> today&#8217;s high-yield savings accounts rates</a> in 2015, it wouldn&#8217;t need to save another penny.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Another reason Wallace said he prefers leasing over buying is that he gets a new car every three years. Because he never exceeds the leasing mileage limit, his overall payments are less than the payments would be if he financed the vehicle.&nbsp;
Orman disagreed.&nbsp;
"You only get to drive at 12,000 miles," she said. "You have to have a lease gap insurance. Why don't you do what I do? I bought a car."&nbsp;
Orman said buying a used car is best because a vehicle never increases in value, making it a "lousy investment." This means choosing a reliable car over unnecessary bells and whistles.&nbsp;
Leasing a car is attractive to some people because it offers lower or no down payments with less expensive <a href="https://www.benzinga.com/money/how-much-car-can-i-afford-based-on-my-salary">monthly payments for luxury vehicles</a>. Orman understands that leasing is a more financially available option for some people, which is why she said financing a car is the next-best option instead of leasing.&nbsp;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
<hr class="wp-block-separator has-alpha-channel-opacity" />
When financing a car, Orman said it's important to make sure that you pay it off within three years. If you can't, it's a signal to purchase a cheaper vehicle. In a 2017 blog post, Orman said buyers should spend the least amount possible on a car because paying less will help them pay off the car faster.&nbsp;
Once the car is paid off, Orman advises hanging onto it for as long as possible. She keeps her cars for 12 years, which frees up money to be spent on other things like investments, saving for <a href="https://www.benzinga.com/personal-finance/24/04/38412735/dave-ramsey-against-401k-for-education-your-retirement-savings-come-first-even-before-funding-co">retirement</a> or paying off debts.&nbsp;
Orman said that if you follow her advice and buy a car with a three-year loan instead of leasing, you'll own the vehicle after those 36 months. Depending on your mileage and how well you take care of your car, you could keep driving it for at least another seven years without committing to another loan payment.&nbsp;
While leasing is an option for people seeking cheaper monthly payments, lower down payments and perhaps do not drive as often, buying can put you financially ahead in the long term.&nbsp;
Read Next:
<ul>
<li>Are you secretly doing better with your money than you think?<a href="https://www.benzinga.com/money/money-pickle-financially-healthy"> Here are some signs you&#8217;re financially healthy.</a></li>
<li>Warren Buffett flipped his neighbor's $67,000 life savings into a $50 million fortune —<a href="https://www.benzinga.com/money/advisor-adv-warren-buffett"> How much is that worth today?</a></li>
</ul>

Personal Finance

Suze Orman Calls Car Leasing The 'Biggest Waste Of Money' And Advises To Buy Rather Than Lease

JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Neutral and lowers the price target from $159 to $158.

JP Morgan Maintains Neutral on Clorox, Lowers Price Target to $158

Toyota Motor North America Reported April 2024 U.S. Sales Of 211,818 Vehicles, Up 13.7% On A Volume Basis

IPOs

Viking Holdings IPO Indicating $27/Share; IPO Priced At $24/Share

WIIM

Ryerson Holding shares are trading lower following a Q1 EPS miss.

TC BioPharm Ltd (TCBP) is down -6.49%% today. TCBP has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on TCBP!See Full TCBP ReportTCBP stock closed at $1.54 and is down -$0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most

Premarket Mover: TC BioPharm Ltd (TCBP) Down 6.49%

TC BioPharm Ltd (TCBP) is around the bottom of the Biotechnology industry according to InvestorsObserver. TCBP received an overall rating of 39, which means that it scores higher than 39 percent of all stocks. TC BioPharm Ltd also achieved a score of 28 in the Biotechnology industry, putting it above 28 percent of Biotechn

Is TC BioPharm Ltd (TCBP) a Good Choice in Biotechnology Friday?

The 4 rating InvestorsObserver gives to TC BioPharm Ltd (TCBP)  stock puts it near the middle of the Healthcare sector.In addition to scoring higher than 34 percent of stocks in the Healthcare sector, TCBPâ€&#x2122;s 4 overall rating means the stock scores better than 4 of all stocks. TCBP has an Overall Score of 4. Find out what t

Can TC BioPharm Ltd (TCBP) Stock Rise to the Top of Healthcare Sector Monday?

TCBP to raise treatment capacity with expanded manufacturing process

TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is heading higher on Thursday after the company announced an acquisition that would beef up its therapeutic platform.



According to <a href="https://finance.yahoo.com/news/tcbp-announces-execution-non-binding-123000295.html">a news report</a>, TC BioPharm has executed a non-binding letter of intent for the proprietary manufacturing process of two allogeneic CAR-NK therapeutics. This includes CD-70 CAR NK technology and HER2 CAR-NK technology that both target solid tumors.



TC BioPharm is excited about this acquisition as the new therapies could perform well in combination with its own TCB-008. It also believes that they have the potential to be used as monotherapies.



TC BioPharm CEO Bryan&nbsp;Kobel said the following about the acquisition plans.




&ldquo;This proposed asset acquisition would leverage our strengths in optimizing manufacturing processes and developing new cell therapies rapidly to the clinical stage, as well as our core asset on asset base expansion and combination efforts with TCB-008. By merging complimentary technologies under one roof we believe the potential exit value of TCBP is increased.&rdquo;




<h2>How This Affects TCBP Stock</h2>



News of the platform acquisitions have shares of TCBP stock experiencing heavy trading on Thursday. This has more than 70 million shares of the stock trading hands as of this writing. That&rsquo;s a major surge when compared to its daily average trading volume of about 3.3 million shares.



TCBP stock is up 78.2% as of Thursday morning. However, the shares are still down 26.5% since the start of the year.



Investors will find even more of the most recent stock market stories ready to go down below!



We are offering insight into all of the hottest stock market news for Thursday! That includes what&rsquo;s happening with shares of HubSpot&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/hubs-stock-quote/">HUBS</a>) stock, Tevogen Bio&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tvgn-stock-quote/">TVGN</a>) stock and <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a> today. You can catch up on this at the following links!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/hubs-stock-alert-hubspot-surges-on-report-google-is-eyeing-a-buy/">HUBS Stock Alert: HubSpot Surges on Report Google Is Eyeing a Buy</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-tevogen-bio-tvgn-stock-up-46-today/">Why Is Tevogen Bio (TVGN) Stock Up 46% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/cannabis-stocks-alert-3-big-reasons-tlry-acb-cgc-and-sndl-keep-gaining/">Cannabis Stocks Alert: 3 Big Reasons TLRY, ACB, CGC and SNDL Keep Gaining</a></li>
</ul>On <a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a> and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-tc-biopharm-tcbp-stock-up-78-today/">Why Is TC Biopharm (TCBP) Stock Up 78% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is TC Biopharm (TCBP) Stock Up 78% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is getting a boost on Thursday following the cyber security solutions company&rsquo;s <a href="https://finance.yahoo.com/news/hub-cyber-security-acquires-qpoint-115000849.html">acquisition of QPoint Technologies</a>.



Hub Cyber Security confirms that it now owns 100% of QPoint Technologies in a cash transaction. HUBC didn&rsquo;t say how much money it paid to acquire the software company or provide any other financial details of the transaction.



What we do know is that Hub Cyber Security purchased QPoint Technologies to enhance its own cyber security offerings. This is one of the areas QPoint Technologies focuses on. The others are software engineering, testing, ICT, web, mobile, project management as well as complex integration processes.



Hub Cyber Security also notes that QPoint Technologies brings strong financial performance with it. That includes 2023 revenue of about $23 million and customer growth of more than 80% year-over-year.



Hub Cyber Security CEO Noah Hershcoviz said this about the deal.




&ldquo;Completing the acquisition of QPoint now is part of our strategy aimed at fortifying our cybersecurity infrastructure, enhancing our operational resilience, and ultimately increasing shareholder value.&rdquo;




<h2>HUBC Stock Movement on Thursday</h2>



Hub Cyber Security stock is seeing heavy trading on Thursday alongside this acquisition news. That has more than 8 million shares changing hands as of this writing. That&rsquo;s already well above its daily average trading volume of about 513,000 shares.



HUBC stock is up 18.9% as of Thursday morning but is down 63.8% year-to-date.



Investors will find even more of the most recent stock market stories ready to go below!



We have all of the hottest market news worth reading about on Thursday! Among that is what&rsquo;s happening with Intuitive Machines&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lunr-stock-quote/">LUNR</a>), Flora Growth&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/flgc-stock-quote/">FLGC</a>) and TC BioPharm&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock today. All of this info is ready at the following links!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/lunr-stock-alert-intuitive-machines-nabs-nasa-contract/">LUNR Stock Alert: Intuitive Machines Nabs NASA Contract</a></li>



<li><a href="https://investorplace.com/2024/04/flgc-stock-why-flora-growth-is-down-15-despite-major-cannabis-rally/">FLGC Stock: Why Flora Growth Is Down 15% Despite Major Cannabis Rally</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-tc-biopharm-tcbp-stock-up-78-today/">Why Is TC Biopharm (TCBP) Stock Up 78% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/hubc-stock-hub-cyber-security-pops-on-qpoint-acquisition/">HUBC Stock: Hub Cyber Security Pops on QPoint Acquisition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HUBC Stock: Hub Cyber Security Pops on QPoint Acquisition

BRNS, UPC and KWE among mid-day movers

Altice USA, Genfit, Brooge Energy among premarket losers' pack

BSGM, WAVE and TCBP among pre-market losers

ACRV

AEHL

ANGH

ATUS

AUUD

BCAN

BRNS

BROG

BSGM

CLRO

DCGO

GNFT

LASE

LUNR

MSGM

NOTV

PDYN

PRFX

REPX

SOUN

WAVE

ZOOZ

Press Releases

TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe

TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial

TCBP Announces Shareholder Update Call on March 5th 2024

Entertainment

General

Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"

Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP

TCBP Announces Exercise of Series D Warrants For Cash

TCBP Adjourns General Meeting Until a Later Date

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TC BioPharm (Holdings) Stock (NASDAQ:TCBP), Short Interest Report

People Also Watch